Viracta Therapeutics Price on May 14, 2024
| VIRXDelisted Stock | USD 0.03 0 7.38% |
If you're considering investing in Viracta Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Viracta Therapeutics stands at 0.03, as last reported on the 26th of February, with the highest price reaching 0.04 and the lowest price hitting 0.03 during the day. Viracta Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14 % return per unit of risk over the last 3 months. Viracta Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Viracta Therapeutics' Coefficient Of Variation of (692.16), variance of 193.48, and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide.
Viracta Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Viracta |
Sharpe Ratio = -0.1445
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VIRX |
Estimated Market Risk
| 13.91 actual daily | 96 96% of assets are less volatile |
Expected Return
| -2.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Viracta Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viracta Therapeutics by adding Viracta Therapeutics to a well-diversified portfolio.
Viracta Therapeutics Valuation on May 14, 2024
It is possible to determine the worth of Viracta Therapeutics on a given historical date. On May 14, 2024 Viracta was worth 0.76 at the beginning of the trading date compared to the closed value of 0.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Viracta Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Viracta Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Viracta Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Viracta Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.79 | 0.81 | 0.76 | 0.77 | 40,061 | |
05/14/2024 | 0.76 | 0.84 | 0.76 | 0.80 | 30,814 |
| 0.83 | 0.87 | 0.79 | 0.84 | 141,730 |
| Backtest Viracta Therapeutics | | | Viracta Therapeutics History | | | Viracta Therapeutics Valuation | Previous | Next |
Viracta Therapeutics Trading Date Momentum on May 14, 2024
| On May 15 2024 Viracta Therapeutics was traded for 0.84 at the closing time. The top price for the day was 0.87 and the lowest listed price was 0.79 . The trading volume for the day was 141.7 K. The trading history from May 15, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 5.00% . The trading price change against the current closing price is 5.00% . |
Viracta Therapeutics Fundamentals Correlations and Trends
By evaluating Viracta Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Viracta Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Viracta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Viracta Therapeutics Pink Sheet history
Viracta Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Viracta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Viracta Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Viracta Therapeutics stock prices may prove useful in developing a viable investing in Viracta Therapeutics
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Viracta Therapeutics, Inc. was incorporated in 1998 and is headquartered in Cardiff-by-the-Sea, California. Viracta Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 31 people.
Viracta Therapeutics Pink Sheet Technical Analysis
Viracta Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Viracta Therapeutics Period Price Range
Low | February 26, 2025
| High |
0.00 | 0.00 |
Viracta Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Viracta Therapeutics February 26, 2025 Market Strength
Market strength indicators help investors to evaluate how Viracta Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viracta Therapeutics shares will generate the highest return on investment. By undertsting and applying Viracta Therapeutics pink sheet market strength indicators, traders can identify Viracta Therapeutics entry and exit signals to maximize returns
Viracta Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Viracta Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Viracta Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Viracta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.99) | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | (0.48) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Viracta Pink Sheet
If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |